Skip to search.
 TSX Down 2.15% TSX Ventures Down 1.81%

VIVUS Inc. (VVUS)

-NasdaqGS
2.33 Down 0.14(5.67%) 3:59PM EDT
|After Hours : 2.33 0.00 (0.00%) 5:26PM EDT
Add to Portfolio
Prev Close:2.47
Open:2.42
Bid:2.25 x 300
Ask:2.44 x 8400
1y Target Est:4.50
Beta:1.76
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:2.32 - 2.47
52wk Range:2.22 - 5.45
Volume:1,097,419
Avg Vol (3m):1,084,430
Market Cap:241.89M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSDown 5.67%241.89M
LLYDown 2.41%88.72B
GSKDown 2.01%101.50B
PFEDown 0.97%206.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.84
Quarterly EPS Est (Jun-15) :-0.23
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-3.74

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback